Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ultragenyx Pharmaceutical (RARE) Asset Utilization Ratio (2016 - 2025)

Ultragenyx Pharmaceutical (RARE) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.49 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 34.26% to 0.49 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.49 through Dec 2025, up 34.26% year-over-year, with the annual reading at 0.44 for FY2025, 18.56% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.49 at Ultragenyx Pharmaceutical, down from 0.5 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.5 in Q3 2025, with the low at 0.2 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.31 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 93.45% in 2021, then decreased 2.61% in 2022.
  • Over 5 years, Asset Utilization Ratio stood at 0.23 in 2021, then decreased by 1.73% to 0.23 in 2022, then soared by 38.48% to 0.32 in 2023, then grew by 15.79% to 0.37 in 2024, then surged by 34.26% to 0.49 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.49, 0.5, and 0.47 for Q4 2025, Q3 2025, and Q2 2025 respectively.